Sears Pharmaceuticals (Rights to Rosu Duo) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Sears Pharmaceuticals (Rights to Rosu Duo) General Information

Description

Portfolio of rights to a drug in South Korea. The drug is used for the treatment of hyperlipidemia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • South Korea
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
HLB Pharmaceutical
Corporate Office
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sears Pharmaceuticals (Rights to Rosu Duo) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sears Pharmaceuticals (Rights to Rosu Duo)‘s full profile, request access.

Request a free trial

Sears Pharmaceuticals (Rights to Rosu Duo) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sears Pharmaceuticals (Rights to Rosu Duo)‘s full profile, request access.

Request a free trial

Sears Pharmaceuticals (Rights to Rosu Duo) FAQs

  • Where is Sears Pharmaceuticals (Rights to Rosu Duo) headquartered?

    Sears Pharmaceuticals (Rights to Rosu Duo) is headquartered in South Korea.

  • What industry is Sears Pharmaceuticals (Rights to Rosu Duo) in?

    Sears Pharmaceuticals (Rights to Rosu Duo)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Sears Pharmaceuticals (Rights to Rosu Duo) a private or public company?

    Sears Pharmaceuticals (Rights to Rosu Duo) is a Private company.

  • What is Sears Pharmaceuticals (Rights to Rosu Duo)’s current revenue?

    The current revenue for Sears Pharmaceuticals (Rights to Rosu Duo) is .

  • Who are Sears Pharmaceuticals (Rights to Rosu Duo)’s investors?

    Sears Pharmaceutical has invested in Sears Pharmaceuticals (Rights to Rosu Duo).

  • When was Sears Pharmaceuticals (Rights to Rosu Duo) acquired?

    Sears Pharmaceuticals (Rights to Rosu Duo) was acquired on 24-Nov-2023.

  • Who acquired Sears Pharmaceuticals (Rights to Rosu Duo)?

    Sears Pharmaceuticals (Rights to Rosu Duo) was acquired by HLB Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process